Zelrix electronic anti-migraine patch heads to the FDA for review

[img]http://www.blogcdn.com/www.engadget.com/media/2011/01/zelrix-patch-01-23-2011.jpg
[/img]
We've seen some electronic devices that promise to cure migraines in
the past, but NuPathe's Zelrix patch certainly seems to be among the
most practical, and it's just gotten one step closer to the US market.
The company recently announced that the FDA has accepted its filing
for a New Drug Application, and it says it now has a target date of
August 29, 2011 for the FDA to complete its review. As for the patch
itself, it's a single-use patch that relies on a mild electrical
current to "actively transport" the anti-migraine drug sumatriptan
through the skin using a process called iontophoresis. That, NuPathe
says, not only allows for a more consistent and controlled delivery of
the drug, but it also circumvents the nausea and vomiting that can
occur when taking the medication orally -- which the company notes can
be enough to cause some folks to avoid taking the medication
altogether. Head on past the break for the complete press release.